These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 30565028

  • 1. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade.
    Iwadate Y, Matsutani T, Hara A, Hirono S, Ikegami S, Kobayashi M, Ito D, Kawauchi D, Horiguchi K, Tamiya A, Higuchi Y.
    J Neurooncol; 2019 Jan; 141(1):205-211. PubMed ID: 30565028
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.
    Ahluwalia MS, Xie H, Dahiya S, Hashemi-Sadraei N, Schiff D, Fisher PG, Chamberlain MC, Pannullo S, Newton HB, Brewer C, Wood L, Prayson R, Elson P, Peereboom DM.
    J Neurooncol; 2015 Mar; 122(1):111-9. PubMed ID: 25534576
    [Abstract] [Full Text] [Related]

  • 3. Favorable long-term outcome of low-grade oligodendrogliomas irrespective of 1p/19q status when treated without radiotherapy.
    Iwadate Y, Matsutani T, Hasegawa Y, Shinozaki N, Higuchi Y, Saeki N.
    J Neurooncol; 2011 May; 102(3):443-9. PubMed ID: 20721680
    [Abstract] [Full Text] [Related]

  • 4. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
    McNamara MG, Jiang H, Lim-Fat MJ, Sahebjam S, Kiehl TR, Karamchandani J, Coire C, Chung C, Millar BA, Laperriere N, Mason WP.
    Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
    [Abstract] [Full Text] [Related]

  • 5. Loss of 1p, 19q, and 10q heterozygosity prospectively predicts prognosis of oligodendroglial tumors--towards individualized tumor treatment?
    Ramirez C, Bowman C, Maurage CA, Dubois F, Blond S, Porchet N, Escande F.
    Neuro Oncol; 2010 May; 12(5):490-9. PubMed ID: 20156805
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
    Li YX, Shi Z, Aibaidula A, Chen H, Tang Q, Li KK, Chung NY, Chan DT, Poon WS, Mao Y, Wu J, Zhou L, Chan AK, Ng HK.
    Oncotarget; 2016 Oct 04; 7(40):64615-64630. PubMed ID: 27556304
    [Abstract] [Full Text] [Related]

  • 11. Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases.
    Scheie D, Meling TR, Cvancarova M, Skullerud K, Mørk S, Lote K, Eide TJ, Helseth E, Beiske K.
    Neuro Oncol; 2011 Nov 04; 13(11):1225-33. PubMed ID: 21856683
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma.
    Andrews C, Prayson RA.
    Ann Diagn Pathol; 2020 Jun 04; 46():151519. PubMed ID: 32305004
    [Abstract] [Full Text] [Related]

  • 14. Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.
    Frenel JS, Leux C, Loussouarn D, Le Loupp AG, Leclair F, Aumont M, Mervoyer A, Martin S, Denis MG, Campone M.
    J Neurooncol; 2013 Aug 04; 114(1):85-91. PubMed ID: 23681562
    [Abstract] [Full Text] [Related]

  • 15. Co-deletion of 1p/19q as Prognostic and Predictive Biomarker for Patients in West Bohemia with Anaplastic Oligodendroglioma.
    Polivka J, Polivka J, Repik T, Rohan V, Hes O, Topolcan O.
    Anticancer Res; 2016 Jan 04; 36(1):471-6. PubMed ID: 26722084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas.
    Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M, Banerjee R, Forsyth P, Rich K, Perry A.
    J Neuropathol Exp Neurol; 2004 Apr 04; 63(4):314-22. PubMed ID: 15099021
    [Abstract] [Full Text] [Related]

  • 19. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.
    van den Bent MJ, Looijenga LH, Langenberg K, Dinjens W, Graveland W, Uytdewilligen L, Sillevis Smitt PA, Jenkins RB, Kros JM.
    Cancer; 2003 Mar 01; 97(5):1276-84. PubMed ID: 12599236
    [Abstract] [Full Text] [Related]

  • 20. Anaplastic oligodendroglial tumors harboring 1p/19q deletion can be successfully treated without radiotherapy.
    Iwadate Y, Matsutani T, Shinozaki N, Saeki N.
    Anticancer Res; 2011 Dec 01; 31(12):4475-9. PubMed ID: 22199318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.